Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
JAMA|January 3, 1977
Chronic active hepatitis in hepatitis B surface antigen (HBsAg) carriers. The need for liver biopsyR SamplinerPreventive Medicine|September 1, 1989
Barrett's esophagus: a model premalignant lesion for adenocarcinomaH S Garewal, R SamplinerJournal of Clinical Pharmacology|January 1, 1984
Influence of ascites on tobramycin pharmacokineticsR Sampliner, D Perrier, R Powell, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|December 1, 1994
Demonstration of a field defect in gastric intestinal metaplasia by biological marker analysisH S Garewal, B Fennerty, R Sampliner, et al.Digestive Diseases and Sciences|February 1, 1989
Increase in ornithine decarboxylase activity associated with development of dysplasia in Barrett's esophagusH S Garewal, R Sampliner, D Alberts, et al.Cancer Research|April 1, 1996
Reduced bile acid-induced apoptosis in "normal" colorectal mucosa: a potential biological marker for cancer riskH Garewal, H Bernstein, C Bernstein, et al.Cancer Genetics and Cytogenetics|October 15, 1989
Chromosomal rearrangements in Barrett's esophagus. A premalignant lesion of esophageal adenocarcinomaH S Garewal, R Sampliner, Y Liu, et al.Annals of Surgery|March 1, 1987
Natural history of cholelithiasis in patients with alcoholic cirrhosis (cholelithiasis in cirrhotic patients)G Dunnington, E Alfrey, R Sampliner, et al.European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|December 1, 1995
Risk factors for Barrett's oesophagus: a life history approach to behavioural assessment in the distant pastC Ritenbaugh, R Sampliner, M Aickin, et al.The American Journal of Gastroenterology|October 16, 1999
Biomarker studies in reversed Barrett's esophagusH Garewal, L Ramsey, P Sharma, et al.Pageof 3